Read about our active Clinical Innovation Adoption projects here >
The Oxford Academic Health Science Network has defined innovation as: “… an idea, service or product, new to the NHS or applied in a way that is new to the NHS, which significantly improves the quality of health and care, and delivers value for money, wherever it is applied.”
The Oxford AHSN established its Clinical Innovation Adoption (CIA) programme to speed up widespread adoption of clinical innovation (innovations that are ready to go to market and have a strong evidence base) to improve patient outcomes and reduce costs.
The programme has worked with innovators to develop an exemplar process to assess innovations for uptake. It has evaluated more than 300 innovations, taking account of potential benefits, impact on patient experience, local priorities and ease of implementation. As a result 33 innovations have been implemented covering medicines, devices, digital and diagnostics. Read about our current projects here.
These innovations are sourced from the Oxford AHSN Best Care Clinical Networks, local providers, national awards and National Institute for Health and Care Excellence (NICE) Technology Appraisal (TA) recommendations. They impact on tertiary care, secondary care, community care, mental health care, primary care and self care.
The CIA programme is led by Tracey Marriott.
The key objective is to increase the spread and scale of clinical innovation adoption across the Oxford AHSN region and beyond by:
- assessing the strategic priorities and clinical needs of the population
- identifying the best innovations that address the priorities
- integrating innovations at all relevant points and increasing quality of care and cost efficiency
- working closely with the Oxford AHSN Strategic and Industry Partnerships programme to develop meaningful engagement with industry and gain a shared understanding of how to successfully innovate within the NHS
- empowering the regional workforce with the skills and knowledge to understand and overcome barriers to clinical innovation adoption.
How do we support partners?
- We identify common strategic and clinical priorities across the Oxford AHSN region
- We connect partners through structured networks which share knowledge, experience and best practice
- We find clinical leadership for projects, linking in and setting up networks
- We support partners to plan, gain support internally, implement and evaluate local innovation adoption
- We provide bespoke help to meet partner organisations’ individual needs to achieve change quickly
- We embed change through local training, measuring and monitoring
The Clinical Innovation Adoption programme is overseen by a group chaired by Neil Dardis, Chief Executive of Buckinghamshire Healthcare NHS Trust. This oversight group comprises executives drawn from NHS Trusts and academia in the region. The programme is accountable to the Oxford AHSN Board and Partnership Boards. Read more about Oxford AHSN governance arrangements here.